Prostate cancer detection: Relationship to prostate size

Urology

Volumn 53, Issue 4, 1999, Pages 764-768

  Chen, Michael E ^a,b   Troncoso, Patricia ^a   Johnston, Dennis ^a   Tang, Kuang ^a   Joseph Babaian, R ^a  

^a UNIVERSITY OF TEXAS   (United States)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ARTICLE; CANCER DIAGNOSIS; CANCER GRADING; DISEASE COURSE; PRIORITY JOURNAL; PROSTATE; PROSTATE BIOPSY; PROSTATE CANCER; PROSTATE HYPERTROPHY; PROSTATECTOMY; TUMOR LOCALIZATION; TUMOR VOLUME;

BIOPSY; COMPUTER SIMULATION; HUMANS; MALE; PROSTATE; PROSTATIC NEOPLASMS;

EID: 0033119075     PISSN: 00904295     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0090-4295(98)00574-3     Document Type: Article

References (15)

1. Brawer MK: How to use prostate-specific antigen in the early detection or screening for prostatic carcinoma. CA Cancer J Clin 45: 148-164, 1995.
2. Uzzo RG, Wei JT, Waldbaum RS, et al: The influence of prostate size on cancer detection. Urology 46: 831-836, 1995.
3. Karakiewicz PI, Bazinet M, Aprikian AC, et al: Outcome of sextant biopsy according to gland volume. Urology 49: 5559, 1997.
4. Chen ME, Troncoso P, Johnston D, et al: Optimization of prostate biopsies using computer based analysis. J Urol 158: 2168-2175, 1997.
5. Babaian RJ, Troncoso P, Steelhammer LC, et al: Tumor volume and prostate-specific antigen: implications for early detection and defining a window of curability. J Urol 154: 1808-1812, 1995.
6. Babaian RJ, Fritsch HA, and Evans RB: Prostate-specific antigen and prostate gland volume: correlation and clinical application. J Clin Lab Anal 4: 135-137, 1990.
7. Kojima M, Troncoso P, and Babaian RJ: Influence of noncancerous prostatic tissue volume on prostate-specific antigen. Urology 51: 293-299, 1998.
8. Naughton C, Humphrey PA, Smith D, et al: The value of ultrasound determined prostate size in predicting the number of core biopsies needed to detect clinical prostate cancer (abstract). J Urol 157: 64, 1997.
9. Nava L, Montorsi F, Consonni P, et al: Results of a prospective randomized study comparing 6, 12 and 18 transrectal, ultrasound guided, sextant biopsies in patients with elevated PSA, normal DRE and normal prostatic ultrasound (abstract). J Urol 157: 59, 1997.
10. Stamey TA, Freiha FS, McNeal JE, et al: Localized prostate cancer. Relationship of tumor volume to clinical significance for treatment of prostate cancer. Cancer 71(3 suppl): 933-938, 1993.
11. Epstein JI, Walsh PC, Carmichael M, et al: Pathologic and clinical findings to predict tumor extent of nonpapable (stage Tic) prostate cancer. JAMA 271: 368-374, 1994.
12. Goto Y, Ohori M, Arakawa A, et al: Distinguishing clinically important from unimportant prostate cancers before treatment: value of systematic biopsies. J Urol 156: 1059-1063, 1996.
13. Iczkowski KA, Bassler TJ, Schwob VS, et al: Diagnosis of "suspicious for malignancy" in prostate biopsies: predictive value for cancer. Urology 51: 749-758, 1998.
14. Dugan JA, Bostwick DG, Myers RP, et al: The definition and preoperative prediction of clinically insignificant cancer. JAMA 275: 288-294, 1996.
15. Babaian RJ, Kojima M, Ramirez El, et al: Comparative analysis of prostate specific antigen and its indexes in the detection of prostate cancer. J Urol 156: 432-437, 1996.